|
IL72729A
(en)
|
1983-09-26 |
1988-02-29 |
Lilly Co Eli |
Trans(+_)octahydropyrazole-ring alkylated pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
|
|
GB8828669D0
(en)
|
1988-12-08 |
1989-01-11 |
Lilly Industries Ltd |
Organic compounds
|
|
DE69430373T2
(de)
|
1993-08-06 |
2002-12-12 |
Smithkline Beecham S.P.A., Baranzate Di Bollate |
Hydroisochinolinderivate
|
|
US5696130A
(en)
|
1994-12-22 |
1997-12-09 |
Ligand Pharmaceuticals Incorporated |
Tricyclic steroid receptor modulator compounds and methods
|
|
EP1061919A4
(en)
|
1998-03-10 |
2002-09-04 |
Res Triangle Inst |
NOVEL OPIOUS COMPOUNDS AND PROCESSES FOR THEIR PREPARATION AND USE
|
|
US6166013A
(en)
|
1998-07-30 |
2000-12-26 |
Abbott Laboratories |
Glucocortiocoid-selective agents
|
|
WO2000043017A1
(en)
|
1999-01-21 |
2000-07-27 |
Steroidogenesis Inhibitors International |
Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
|
|
GB9911053D0
(en)
|
1999-05-12 |
1999-07-14 |
Pharmacia & Upjohn Spa |
4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
|
|
GB0010683D0
(en)
|
2000-05-03 |
2000-06-28 |
Univ Bristol |
Cancer therapy
|
|
US6583180B2
(en)
|
2001-02-14 |
2003-06-24 |
Abbott Laboratories |
Glucocorticoid receptor modulators
|
|
AU2002258399A1
(en)
|
2001-02-16 |
2002-09-19 |
Medical College Of Georgia Research Institute, Inc. |
Use of trail and antiprogestins for treating cancer
|
|
AU2002355929A1
(en)
|
2001-07-17 |
2003-03-03 |
Smithkline Beecham Corporation |
Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
|
|
JP2004537563A
(ja)
|
2001-07-23 |
2004-12-16 |
コーセプト セラピューティクス， インコーポレイテッド |
抗神経病薬誘導性体重増加を予防するための方法
|
|
CN1556708A
(zh)
|
2001-08-31 |
2004-12-22 |
�Ƹ��� |
抑制成年唐氏综合症患者认知退化的方法
|
|
AU2003214879B2
(en)
|
2002-01-22 |
2008-02-07 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
JP2005535664A
(ja)
|
2002-07-02 |
2005-11-24 |
コーセプト セラピューティクス， インコーポレイテッド |
インターフェロン−α治療に関連した精神病を処置するための方法
|
|
CA2499150A1
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
US20040229855A1
(en)
|
2003-02-04 |
2004-11-18 |
Corcept Therapeutics, Inc. |
Antiglucocorticoids for the treatment of postpartum psychosis
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
AU2004270154A1
(en)
|
2003-09-03 |
2005-03-17 |
Wyeth |
Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
|
|
DK1761497T3
(da)
|
2004-01-09 |
2008-11-03 |
Corcept Therapeutics Inc |
Azadecalinglucocorticoidreceptormodulatorer
|
|
AU2005217646A1
(en)
|
2004-02-26 |
2005-09-09 |
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
A novel cofactor that modulates steroid receptor activities
|
|
AU2005222421B2
(en)
|
2004-03-09 |
2010-09-23 |
Corcept Therapeutics, Inc. |
Fused ring azadecalin glucocorticoid receptor modulators
|
|
JP4958774B2
(ja)
|
2004-07-02 |
2012-06-20 |
コーセプト セラピューティクス， インコーポレイテッド |
改変されたピリミジン糖質コルチコイドレセプター調節因子
|
|
EP2757099B1
(en)
|
2005-05-12 |
2017-08-23 |
AbbVie Bahamas Limited |
Apoptosis promoters
|
|
US7790745B2
(en)
|
2005-10-21 |
2010-09-07 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline LXR Modulators
|
|
US7640389B2
(en)
|
2006-02-28 |
2009-12-29 |
Freescale Semiconductor, Inc. |
Non-volatile memory having a multiple block erase mode and method therefor
|
|
EP1932843A1
(en)
|
2006-12-14 |
2008-06-18 |
sanofi-aventis |
Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals
|
|
JP2011503111A
(ja)
|
2007-11-12 |
2011-01-27 |
バイパー サイエンシズ，インコーポレイティド |
Ｐａｒｐ阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療
|
|
US20120022121A1
(en)
|
2007-11-29 |
2012-01-26 |
Dalton James T |
Indoles, derivatives and analogs thereof and uses therefor
|
|
US20090156672A1
(en)
|
2007-12-17 |
2009-06-18 |
Northwestern University |
Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities
|
|
US8003689B2
(en)
|
2008-06-20 |
2011-08-23 |
Gtx, Inc. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
CA2728563C
(en)
|
2008-07-01 |
2017-05-30 |
Corcept Therapeutics, Inc. |
Use of mifepristone for the treatment of amyotrophic lateral sclerosis
|
|
US20100135956A1
(en)
|
2008-11-21 |
2010-06-03 |
Auspex Pharmaceuticals, Inc. |
Steroid modulators of progesterone receptor and/or glucocorticoid receptor
|
|
JP5637568B2
(ja)
|
2009-05-12 |
2014-12-10 |
コーセプト セラピューティクス， インコーポレイテッド |
固体形態および調製のためのプロセス
|
|
EP2545173A2
(en)
|
2010-03-12 |
2013-01-16 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
|
US8710035B2
(en)
|
2010-03-24 |
2014-04-29 |
The University Of Chicago |
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
|
|
MX2013002186A
(es)
|
2010-08-27 |
2013-06-28 |
Corcept Therapeutics Inc |
Moduladores de azadecalina de piridil-amina fusionada.
|
|
US9314473B2
(en)
|
2011-02-03 |
2016-04-19 |
Pop Test Oncology Limited Liability Company |
System and method for diagnosis and treatment
|
|
EP2671086B1
(en)
|
2011-02-03 |
2018-04-25 |
Pop Test Oncology LLC |
System and method for diagnosis and treatment
|
|
KR101925955B1
(ko)
|
2011-03-18 |
2018-12-06 |
코어셉트 쎄라퓨틱스, 잉크. |
피리미딘 사이클로헥실 글루코코르티코이드 수용체 조절제
|
|
WO2013039916A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
Compositions for and methods of treatment and enhanced detection of non-pituitary tumors
|
|
ES2665580T3
(es)
|
2011-11-11 |
2018-04-26 |
Gilead Apollo, Llc |
Inhibidores de ACC y usos de los mismos
|
|
PT3111950T
(pt)
|
2012-02-24 |
2021-10-19 |
Univ Chicago |
Métodos e composições relacionadas com antagonismo recetor de glucocorticoide e cancro da próstata
|
|
US20130225633A1
(en)
|
2012-02-27 |
2013-08-29 |
Corcept Therapeutics, Inc. |
Phenyl heterocycloalkyl glucocorticoid receptor modulators
|
|
HUE029038T2
(en)
|
2012-05-25 |
2017-01-30 |
Janssen Sciences Ireland Uc |
Uracil spirooxetan nucleosides
|
|
PT3338781T
(pt)
*
|
2012-05-25 |
2019-11-29 |
Corcept Therapeutics Inc |
Moduladores de recetores de glucocorticoides de azadecalina fundida com heteroaril-cetonas
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
EP4219494B1
(en)
|
2013-11-25 |
2026-03-25 |
Corcept Therapeutics Incorporated |
Octahydro fused azadecalin glucocorticoid receptor modulators
|
|
US9452255B2
(en)
|
2014-07-21 |
2016-09-27 |
Medtronic Minimed, Inc. |
Smart connection interface
|
|
EP3006453A1
(en)
|
2014-10-08 |
2016-04-13 |
Cosmo Technologies Ltd. |
17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
|
|
US10047157B2
(en)
|
2014-12-19 |
2018-08-14 |
Alder Biopharmaceuticals, Inc. |
Humanized anti-ACTH antibodies and use thereof
|
|
WO2016140867A1
(en)
|
2015-03-02 |
2016-09-09 |
Corcept Therapeutics, Inc. |
Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors
|
|
WO2016141365A1
(en)
|
2015-03-05 |
2016-09-09 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of glucocorticoid receptor
|
|
US9598459B2
(en)
|
2015-08-03 |
2017-03-21 |
Pop Test Oncology Llc |
Pharmaceutical compositions and methods
|
|
KR20180052120A
(ko)
|
2015-08-13 |
2018-05-17 |
코어셉트 쎄라퓨틱스, 잉크. |
Acth-의존성 쿠싱 증후군을 감별 진단하는 방법
|
|
MX390517B
(es)
*
|
2016-03-01 |
2025-03-20 |
Corcept Therapeutics Inc |
Uso de moduladores del receptor de glucocorticoides para potenciar inhibidores de puntos de regulacion.
|
|
US9943505B2
(en)
|
2016-09-09 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Glucocorticoid receptor modulators to treat pancreatic cancer
|
|
PH12017000049A1
(en)
|
2017-02-20 |
2018-08-29 |
S Heilveil Peter |
Aerial cable spacer
|
|
SG11201908790PA
(en)
|
2017-03-31 |
2019-10-30 |
Corcept Therapeutics Inc |
Glucocorticoid receptor modulators to treat cervical cancer
|
|
AU2019404026B2
(en)
|
2018-12-19 |
2023-06-08 |
Corcept Therapeutics Incorporated |
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
|
|
CA3131263C
(en)
*
|
2019-02-22 |
2024-01-02 |
Corcept Therapeutics Incorporated |
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
|
|
AU2020239920A1
(en)
|
2019-03-18 |
2021-11-04 |
Arnold L. Newman |
Method of improving insulin sensitivity
|
|
EP4103180A4
(en)
|
2020-02-10 |
2024-03-13 |
Corcept Therapeutics Incorporated |
METHOD FOR STIMULATING AN ANTI-TUMOR RESPONSE USING A SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR
|
|
WO2022134033A1
(en)
|
2020-12-25 |
2022-06-30 |
Corcept Therapeutics Incorporated |
Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
IL317734A
(en)
|
2022-06-28 |
2025-02-01 |
Corcept Therapeutics Inc |
METHODS FOR PREPARING HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
|
|
WO2024077169A1
(en)
|
2022-10-06 |
2024-04-11 |
Corcept Therapeutics Incorporated |
Formulations of glucocorticoid receptor modulators
|